Zobrazeno 1 - 10
of 10
pro vyhledávání: '"K N, Uglyanitsa"'
Publikováno v:
Health and Ecology Issues. :121-126
Objective: clinical and morphological evaluation of neoadjuvant polychemotherapy (NPС) and intravenous laser irradiation of blood (ILIB) in the treatment of locally advanced breast cancer (LABC). Material and methods: NPC was carried out only in the
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
We developed a method using high-performance liquid chromatography for the determination of the main fluorescent component of Ukrain, a novel antitumor and immune-stimulating drug. Our method was based on ion-pair separation of Ukrain from perchloric
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
This study included 15 patients with newly diagnosed prostate cancer with an average age of 71 years (62-85 years). The patients received Ukrain at a total dose of 100 mg (10 mg intravenously every second day, 10 injections altogether). After two to
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
The aim of this study was to compare the efficacy of different Ukrain doses in the combined treatment of 75 patients with breast cancer. The patients were divided into three groups: groups I and II (25 patients each) were treated with 50 mg and 100 m
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
The aim of this study was to elucidate the mechanisms of the anticancer effect of Ukrain by comparing the processes of formation of the pool of free amino acids and their derivatives in the blood plasma and tumor biopsy specimens and unchanged bladde
Autor:
K N, Uglyanitsa, L I, Nefyodov, Y M, Doroshenko, J W, Nowicky, I V, Volchek, W J, Brzosko, Y J, Hodysh
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
A review of the recent literature on the new anticancer drug Ukrain is provided herein. We review Ukrain, a thiophosphate derivative of alkaloids from Chelidonium majus L., its capacity to exert selective cytotoxic and cytostatic effects on tumor cel
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
This study was carried out in 75 patients with histologically confirmed breast cancer. Patients were divided into three groups of 25. The control group received symptomatic corrective therapy prior to mastectomy. The two other groups were given neoad
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
A random group of 50 patients in tumor stages T1-3N0-2M0 was selected from breast cancer patients and given Ukrain therapy by intravenous injection. Twenty-five patients received a total dose of 50 mg Ukrain (5 mg every second day, 10 injections alto
Publikováno v:
Drugs under experimental and clinical research. 26(5-6)
This study comparatively evaluated free amino acid pool formation in patients with T1-3N0-2M0 breast cancer treated with the drug Ukrain (25 patients, i.v. 100 mg/course) in combination with preoperative radiation or neoadjuvant therapies (25 subject
Publikováno v:
Bulletin of Experimental Biology and Medicine. 93:523-525